We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Kodiak Sciences
KOD
$2.84B
| $3.26M | ﹤0.01% |
35,018
-2,097
| -6% | -$201K |
|
1677
PennyMac Financial
PFSI
$4B
| $3.24M | ﹤0.01% |
52,550
-9,786
| -16% | -$595K |
|
|
DNB
1678
DELISTED
Dun & Bradstreet
DNB
| $3.24M | ﹤0.01% |
151,708
+33,670
| +29% | +$754K |
|
|
TVTY
1679
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $3.23M | ﹤0.01% |
122,931
-7,815
| -6% | -$196K |
|
1680
Casella Waste Systems
CWST
$5.75B
| $3.23M | ﹤0.01% |
50,950
-3,587
| -7% | -$238K |
|
|
TWOU
1681
DELISTED
2U Inc
TWOU
| $3.23M | ﹤0.01% |
2,583
+285
| +12% | +$329K |
|
1682
Interface
TILE
$2.04B
| $3.22M | ﹤0.01% |
210,732
-9,189
| -4% | -$132K |
|
1683
Caleres
CAL
$486M
| $3.22M | ﹤0.01% |
118,080
-22,753
| -16% | -$570K |
|
|
MDLA
1684
DELISTED
Medallia, Inc.
MDLA
| $3.22M | ﹤0.01% |
95,426
+8,701
| +10% | +$250K |
|
|
FSR
1685
DELISTED
Fisker Inc.
FSR
| $3.21M | ﹤0.01% |
+166,397
| New | +$2.46M |
|
|
NSTG
1686
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.21M | ﹤0.01% |
49,506
-3,143
| -6% | -$200K |
|
1687
PTC Therapeutics
PTCT
$5.91B
| $3.21M | ﹤0.01% |
75,850
+3,864
| +5% | +$166K |
|
|
LDL
1688
DELISTED
Lydall, Inc.
LDL
| $3.21M | ﹤0.01% |
52,966
-5,763
| -10% | -$222K |
|
|
CHCT
1689
Community Healthcare Trust
CHCT
$446M
| $3.2M | ﹤0.01% |
67,362
+2,766
| +4% | +$135K |
|
1690
Artivion
AORT
$1.29B
| $3.19M | ﹤0.01% |
112,351
-5,103
| -4% | -$139K |
|
1691
Haverty Furniture Companies
HVT
$450M
| $3.19M | ﹤0.01% |
74,550
-6,653
| -8% | -$291K |
|
1692
Agilysys
AGYS
$3.03B
| $3.18M | ﹤0.01% |
55,993
-783
| -1% | -$40.5K |
|
|
NARI
1693
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.18M | ﹤0.01% |
34,105
+15,246
| +81% | +$1.48M |
|
1694
Core Laboratories
CLB
$513M
| $3.18M | ﹤0.01% |
81,591
+1,926
| +2% | +$69K |
|
|
MIME
1695
DELISTED
Mimecast Limited
MIME
| $3.17M | ﹤0.01% |
59,847
-2,481
| -4% | -$117K |
|
1696
Hyatt Hotels
H
$16.9B
| $3.17M | ﹤0.01% |
40,813
+1,782
| +5% | +$144K |
|
1697
BOK Financial
BOKF
$8.78B
| $3.17M | ﹤0.01% |
36,553
-2,384
| -6% | -$213K |
|
1698
WesBanco
WSBC
$4B
| $3.16M | ﹤0.01% |
88,761
-10,775
| -11% | -$404K |
|
1699
United Parks & Resorts
PRKS
$2.09B
| $3.14M | ﹤0.01% |
62,787
-8,809
| -12% | -$467K |
|
1700
Acadia Pharmaceuticals
ACAD
$4.9B
| $3.13M | ﹤0.01% |
128,522
+12,840
| +11% | +$290K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.